Larvol Delta - Alector-Presents-Baseline-Characteristics-for-INVOKE2-Phase-2-Clinical-Trial-of-AL002-at-the-Alzheimers-Association-International-Conference-2024-AAIC

AL002 - Alector, AbbVie

https://www.globenewswire.com/en/news-release/2024/07/28/2919971/0/en/Alector-Presents-Baseline-Characteristics-for-INVOKE-2-Phase-2-Clinical-Trial-of-AL002-at-the-Alzheimer-s-Association-International-Conference-2024-AAIC.html

Jul 28, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next